Abstract -Mycoplasma mycoides subsp. mycoides SC (MmmSC) is the etiological agent of contagious bovine pleuropneumonia (CBPP). Although eradicated in most developed countries, the disease reappeared in Europe in the 1990s. This reappearance may have been caused either by importation from sub-Saharan Africa, where CBPP is still endemic, or by the reemergence of virulent strains in Europe, as suggested by earlier studies. A multilocus sequence analysis scheme has been developed to address this issue and, most importantly, to be able to monitor new epidemics. The alignment of the full genome sequence of the reference strain PG1 and the partial genome sequence of a pathogenic strain allowed the identification of polymorphic sites. Nineteen initial loci were selected within housekeeping genes, genes of unknown function and non coding sequences. The suitability of these loci for genotyping MmmSC strains was first tested on six strains of diverse geographic origin. The analyses showed that the published PG1 sequence contained a number of specific polymorphisms that were therefore of no use for molecular typing. Among the eight informative polymorphic loci finally selected, only one (ftsY) was positioned within a housekeeping gene. Three main groups and 31 different allelic profiles were identified among 51 strains and strain variants examined. Cluster analysis confirmed that European strains from the 1990s did not originate from Africa. It also showed a genetic link between a European strain isolated in 1967 and those found in southern Africa and Australia. This was in agreement with historical data showing that CBPP was introduced in these regions during colonisation in the 19th century.
INTRODUCTION
Mycoplasma mycoides subsp. mycoides SC (MmmSC) is the etiological agent of contagious bovine pleuropneumonia (CBPP) [33] . This disease belongs to the list of notifiable animal diseases from the World Organisation for Animal Health (OIE) because of its eco-20th century thanks to the strict application of stamping out policies. A strategy that combined vaccination campaigns, detection and slaughter of infected animals and control of animal movements allowed Australia to regain a CBPP-free status in 1973 [8] . In sub-Saharan Africa, CBPP was eradicated in the extreme southern part of Africa but remains enzootic elsewhere. The disease was under control in Africa around 1980, when repeated vaccination campaigns were organised to eradicate rinderpest by use of bivalent vaccines that also provided protection against CBPP. However, its prevalence and distribution have extended dramatically since the eradication of rinderpest in 1993, which implies that no more vaccination campaigns have been organised and subsidised [25] . European countries are now free of CBPP, though some of them have experienced sporadic outbreaks at regular intervals. This was the case in Portugal, where CBPP outbreaks were reported in 1935, 1953, and 1993 . Outbreaks were also reported at the border between Spain and France in 1967 and 1982, and in Italy in 1993 [34] . On each occasion, field epidemiological inquiries failed to yield clues regarding the origin of the outbreaks and did not permit to elucidate whether they were the result of reintroduction or resurgence of the disease.
MmmSC, the agent of CBPP, belongs to the so-called Mycoplasma mycoides cluster, which includes six mycoplasma subspecies and groups of strains that are closely related from both a phenotypic and a genetic point of view [9, 10] . The organisms most closely related to MmmSC are M. mycoides subsp. mycoides LC (MmmLC) and M. mycoides subsp. capri (Mmc), which are both etiological agents of contagious agalactia in small ruminants. Recent data have shown that these two subspecies could be grouped into a single entity [45] . Differentiation of the strains belonging to these three taxons is difficult when relying only on the standard growth inhibition technique. Concerning intra-species polymorphism, comparative studies by SDS-PAGE have already shown that strain variability within MmmSC is much more limited than within MmmLC and Mmc [9] . Although MmmSC is thought to be a very homogeneous taxon, previous studies have shown that MmmSC strains could be differentiated using molecular typing assays. Analysis of genomic polymorphism by endonuclease restriction of whole genomic DNA showed that different profiles were obtained with BamHI and PstI [31] and that the profiles corresponding to European strains differed from those of African origin. The use of HindIII allowed distinguishing various vaccine strains [40] . The evidence of multiple copies of insertion elements present in the MmmSC genome allowed the development of new typing tools based on Southern blot hybridisation. The use of IS1296 as a probe allowed the clear differentiation of recent European strains from those of African origin [7] . The observed difference was explained later on by the identification of an 8.8 kbp deletion in the genome of most MmmSC strains of European origin [43] , resulting in a missing IS1296 band. The use of another insertion element, IS1634, also led to different Southern blot profiles [24, 46] although the high copy number of this insertion sequence (N = 60), as compared to that of IS1296 (N = 28), gave rise to profiles that were difficult to analyse. The use of a technique based on sequencing multiple loci, designated multilocus sequence analysis (MLSA), allowed the identification of 15 different allelic profiles within a representative number of MmmSC strains (N = 48) of various origins [22] . In 2004 the whole genome sequence of MmmSC reference strain PG1 was published [48] , opening new opportunities for the development of typing tools. Analysis of the PG1 genome sequence showed that the loci and primer pairs previously selected for MLSA were not the most adequate. Some of the primers hybridised on multiple sites, whilst other targeted sequences were duplicated in the PG1 genome, hampering result interpretation. Comparison of PG1 sequences with the sequences of a pathogenic MmmSC strain, obtained through an ongoing genome sequencing project, allowed the identification of a number of polymorphic sites. The objective of this study was to select a set of polymorphic loci to develop a more precise and robust MLSA scheme in order to type MmmSC strains from all over the world and to elucidate the molecular epidemiology of CBPP. Table I lists the names and origin of the 51 strains and strain variants of MmmSC used in this study. The strains, selected in order to cover the entire geographic distribution of CBPP, were isolated from Africa (N = 41), Europe (N = 5), Australia (N = 2), and India (N = 1), whereas the origin of strains Lederle, Asmara, and PG1 is unknown. The oldest strain of known origin was isolated in 1936 (strain V5 from Australia) and the most recent in 2004 (strain 2004-003 from Zambia). The date of isolation of six strains was not precisely known. Although the majority of the isolates were of bovine origin, a few isolates from small ruminants (Vom, 94158 and 99048) were also included.
MATERIALS AND METHODS

MmmSC strains and isolates
Strains were grown in a modified Hayflick medium containing sodium pyruvate and glucose [39] . At the end of the exponential phase of growth, 2 mL of culture were centrifuged at 12 000 × g for 15 min at 4
• C. The pellet was washed once in PBS, and re-suspended in 100 µL of distilled water, to which 150 µL of lysis buffer (100 mM Tris HCl, pH 8.5; 0.05% Tween 20; 0.24 mg/mL proteinase K) were added. Following incubation at 60
• C for 30 min, proteinase K was heat-inactivated at 95
• C for 5 min. Samples in lysis buffer were stored at -20
• C until analysis and they were added to the PCR mix without further DNA extraction.
Identification of suitable loci for MLSA
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sequences homologous to PG1. Only insertion sequences and large duplicated zones in the PG1 genome, unsuitable for MLSA, were excluded. As a whole, 800 kbp were available for comparison. Alignments were performed using the AlignX program of Vector NTI software (Vector NTI v10.3.0, Invitrogen corporation, Carlsbad, CA, USA). Polymorphic sites were recorded and positioned in the PG1 genomic sequence map. Nineteen polymorphic positions were chosen for initial validation. Seven of them resided in housekeeping genes, six within lipoprotein or transmembrane protein genes and a further six within non-coding sequences and they were all distributed along the entire PG1 genome, as shown in Figure 1 . The suitability of these loci for MLSA was first validated by sequencing the homologous regions of five additional MmmSC strains: the original PG1 strain used for genome sequencing in Sweden and four other strains from Europe (PO1967), East Africa (94111), West Africa (Filfili), and Australia (Gladysdale). Eight potentially interesting loci were then chosen for final validation using the whole set of strains (Tab. II).
PCR and sequencing
PCR was carried out in a 50 µL reaction containing: 0.5 unit of Taq DNA polymerase (Qiagen SA, Courtaboeuf, France) in its corresponding buffer (including 1.5 mM MgCl 2 ), 300 µM of dTTP and dATP, 150 µM of dGTP and dCTP, 0.4 µM of each primer and 1 µL of sample diluted 1/100. Amplifications were performed using GeneAmp PCR Systems 2400 and 9700 (Perkin Elmer, Courtaboeuf, France). Thermal cycling consisted in an initial denaturation step at 94
• C for 5 min, followed by 
cycles of denaturation at 94
• C for 15 s, annealing at 52
• C for 30 s and extension at 72
• C for 90 s. The final extension step was maintained at 72
• C for 7 min. The size and purity of the amplicons were controlled by electrophoretic separation in 1% agarose gels and samples with relevant features were sent to Genome Express (Genome Express Cogenics, Meylan, France) for sequencing with the corresponding primers. Both forward and reverse strands were sequenced systematically.
Allelic profile analysis
The sequences obtained from each corresponding forward and reverse primers were assembled using Vector NTI Suite TM (InfoMax, 2001 ) and the extremities corresponding to single strand sequences or showing aberrant features were trimmed. The sequences obtained from different strains for each locus were aligned using ClustalW (Vector NTI). Polymorphic sites were recorded, carefully checking the corresponding sequence chromatograms. A new allele number was assigned to each change in the nucleotide sequence. In the end, each strain was characterised by an allelic profile, corresponding to the combination of allele numbers for each of the eight selected loci. This resulted in a matrix comprising 31 different allelic profiles (Tab. III), which was analysed using eBURST V3, a software developed for the analysis of multilocus sequence typing (MLST) datasets 1 . Standard parameters were used, except for the number of loci, which was fixed at eight. Each strain was then characterised by a letter, corresponding to its group, followed by a number, corresponding to the allelic profile.
Molecular epidemiology analysis
When the exact origin of the strain was known, the geographic coordinates were inferred from a dedicated website 2 . When this information was not available, a putative geographic location was assigned to the strain, taking into account the known distribution of CBPP in the country. For example, strains originating from Namibia were positioned north of the veterinary fence that separates CBPP infected regions in the North from CBPP-free zones in the South. Strains were then positioned on a map, displaying group and allele numbers.
RESULTS
Choice of MLSA loci and initial validation
The first objective of this study was to find suitable loci for multilocus sequence analysis of MmmSC strains. Nineteen polymorphic sites observed by comparing the genome sequence of MmmSC reference strain PG1 with the partial genome sequence of pathogenic strain 8740-Rita were chosen for initial validation. Five strains, including the original PG1 used for genome sequencing in Sweden and four other strains from diverse geographic origins, were used for this initial validation.
Two loci were considered unsuitable because the polymorphisms that were initially observed between PG1 and 8740-Rita were apparently due to errors in the published PG1 sequence. In Loc-PG1-0330 (lepA) both the G in position 379030 and the T in position 379050 are actually A. These two modifications result in a single amino acid modification in the deduced protein sequence. In Loc-PG1-0191 (trsE), the T in position 227175 should be deleted and a T should be inserted after position 227214. These changes modify significantly the sequence of the trsE product (12 amino acids). Interestingly, when this locus was sequenced in the vaccine strain T1/44, an insertion sequence (IS1634) was found interrupting the trsE gene at position 227363. The putative function of the trsE gene product is not well known, though it may be involved in the transport of large molecules, intracellular trafficking and secretion. The disruption of trsE in strain T1/44 indicates that this gene is not essential, though whether this has contributed to the attenuation of the vaccine strain is yet to be elucidated. Four additional loci were excluded as the polymorphism was found to be limited to the sequence of strain PG1, whereas the other five MmmSC strains exhibited identical sequences. Three of these loci where located within the housekeeping genes fusA (Loc-PG1-0159), glpK (Loc-PG1-0258), and rpoB (Loc-PG1-1008), whereas Loc-PG1-0372 corresponded to a non-coding sequence. Another four loci (Loc-PG1-0145, Loc-PG1-0194, Loc-PG1-0456, and Loc-PG1-0750) were eliminated because they did not add to the discriminatory power of Loc-PG1-0489. Loc-PG1-0233 was also excluded, since only two alleles could be defined in this sequence. All strains of European origin, and none of the other, bore allele 2 in this locus, making it a good tag for this origin. It must be noted that PG1, the origin of which is unknown, also displayed allele 2 in this locus. On the contrary, strain Lederle, which had been used as a vaccine in Spain, displayed allele 1, suggesting that it may not be of European origin. Finally, in Loc-PG1-0194, three alleles were defined, though the results were redundant and did not allow a better differentiation of the strains. In the end, eight loci were selected (Tab. II) to perform MLSA on the whole set of MmmSC strains.
Interestingly, analysis of sequence variations amongst MmmSC strains showed that many coding sequences (CDS) were interrupted in PG1, whereas larger CDS were identified in the other MmmSC strains. This was the case of four out of the eight selected loci. The CDS MSC_0103 and MSC_0104 constituted a single CDS of around 370 amino acids, as well as MSC_0287 and MSC_0288, forming a single CDS of 713 amino acids, and MSC_0710 and MSC_0711, which constituted a single CDS of 934 amino acids. The CDS MSC_0827 was extended from 99 to 344 amino acids.
Robustness of the MLSA
To evaluate the robustness of the method, cultures of pathogenic strain 8740, the same strain at the 11th and 53rd passages and after a passage in bovines (8740-Rita), were analysed. These were considered variants of the same strain, differing only by a few, well characterised, in vitro or in vivo passages. In addition, three strains (94111, Filfili, Gladysdale) were tested in duplicate at three months of interval. No differences were evidenced either between the duplicates or between the four strain variants differing in the number of passages. This result was important to show that the selected loci were stable over a few passages, implying that the sequence differences were correlated to the natural evolution of the strains in vivo. In the case of high mutation rates the signal would be blurred or biased through in vitro passage, whereas in the case of low mutation rates the loci would have been unsuitable for use as molecular epidemiology tools.
Alleles defined in the different loci
Alleles defined in non-coding sequences
Five alleles were defined in locus Loc-PG1-0287. Two alleles gathered the majority of the strains (46 out of 51), with allele 4 found only in Western Africa, while allele 1 had no geographic specificity.
Three alleles were defined in locus Loc-PG1-0827. Forty-one strains bore the same allele. The other alleles corresponded to strains found in Europe and Africa, as well as PG1.
Six alleles were defined in Loc-PG1-0001, with the greatest variability found among strains from West Africa.
Alleles defined in genes of unknown function: Lipoproteins (Lpp) and Conserved hypothetical proteins (Chp)
The smallest number of alleles was 2 for locus Loc-PG1-0710. The observed mutation induced an amino acid modification in the predicted putative lipoprotein (L to S). There was a clear geographic segregation of the alleles (Fig. 2) . With the exception of strain Pillai, all strains found in inter-tropical Africa bore allele 1.
Four different alleles were defined in Loc-PG1-0523. However, some MmmSC strains could not be typed, as this locus was located within the 8.8 kbp deletion that was found to be specific to recent European strains. A fifth allele was therefore created in order to type this last group of strains using eBURST. Interestingly, the only strain of European origin for which this locus could be sequenced, PO1967, bore the same allele as the strains found in southern Africa and Australia. This allele was characterised by six polymorphic positions that differed in other MmmSC strains (Tab. IV). This gave more strength to the genetic link demonstrated by this allele.
Five alleles were defined in locus Loc-PG1-0103. They corresponded to a variable number of five to nine trinucleotide repeats (AAT) coding for asparagine (N) within a gene coding for 
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Loc-PG1-0489 a putative lipoprotein. There was no apparent geographic segregation of the various alleles.
Allele defined in the housekeeping gene ftsY
Six alleles were defined in Loc-PG1-0489, corresponding to ftsY. The majority of the strains were segregated in two alleles, comprising similar numbers (23 and 18 strains respectively). Allele 2 was found only on MmmSC strains from sub-Saharan origin. Allele 4 was displayed by strains from Southern Africa, Australia, and India, as well as by some strains from East Africa. It was also found on one old strain from West Africa and a strain of unknown origin (Lederle), which was formerly used as a vaccine in Europe.
All strains isolated in Europe bore allele 5 on this locus (Fig. 3) , strain Lederle, formerly used as a vaccine in Spain, has an unknown origin.
Strain groups by MLSA analysis
All 51 strains were characterised by an allelic profile and 31 different allelic profiles were identified (Tab. III). The genetic events underlying the description of the various alleles are described in Table IV . Analysis using eBURST allowed the identification of three main groups of strains (comprising 43 strains). Eight strains were included into groups gathering only two strains or considered as singletons. The geographic positioning of the various groups and allelic profiles is shown in Figure 4 .
Group A was the largest, including 25 strains (Fig. 5) . Thirteen different allelic profiles were clustered within this group. The largest (A04 and A12) gathered up to four strains. Group A strains were found mostly in West and central Africa, though some of them were found in East Africa (Fig. 4) . It must be noted that all MmmSC strains isolated after 1994 in East Africa presented the same allelic profile (A05).
Group B was the second largest, including 13 strains that were subdivided into 7 allelic profiles (Fig. 6) . Group B strains were found in southern Africa, East Africa, Australia and India (Fig. 4) . The most common allelic profile (B03) was shared by four strains of various origins (Australia, Tanzania, Sudan, and India). Most of group B strains found in East Africa had been isolated before 1970 (Pillai, T1sr, T2-34, and a vaccine strain received from a laboratory at Asmara, the origin of which remains undetermined).
Group C corresponded to strains found solely in Europe (Fig. 4 and 6) .
Finally, eight strains could not be included into any of the three main groups, as they displayed peculiar allelic profiles. In West Africa peculiar profiles corresponded to old strains isolated in Senegal and Guinea and in East Africa to a vaccine strain (KH3J) also isolated long ago. Two strains isolated recently from northern Ethiopia and Eritrea also bore peculiar allelic profiles. Finally, PG1 was the strain that exhibited the most peculiar allelic profile.
DISCUSSION
Genomic analysis
The objective of this study was to establish a more robust MLSA scheme for MmmSC strains based on whole genome sequence comparison. Analysis of PG1 sequences showed that many primers designed on a previous MLSA scheme [22] hybridised at multiple sites or targeted sequences that were duplicated in the PG1 genome. The initial validation of 19 selected loci in this study revealed that sequencing errors may remain in the published PG1 genome. Out of the 19 initial polymorphic loci, two corresponded to sequencing errors. It must be noted that, if this result was extrapolated to the 267 polymorphic sites found between the sequences of strains PG1 and 8740-Rita, there may be around 20 errors in the published PG1 sequence. Another four out of the 19 polymorphic positions seemed to be specific to the PG1 sequence. The peculiarity of the PG1 genome has already been shown. For example, this strain possesses a large DNA repeat of 24 kbp, which is absent in other MmmSC strains [3] . The peculiarities of PG1 may be due to a natural divergent evolution of the strain. However, it is difficult to substantiate this hypothesis, since Geographic distribution of alleles for Loc-PG1-0489. Six alleles were defined in this locus. Allele 2 was found only on MmmSC strains from subSaharan origin. Allele 4 was displayed by strains from Southern Africa, Australia, and India, as well as by some strains from East Africa. It was also found on one old strain from West Africa and a strain of unknown origin (Lederle), which was formerly used as a vaccine in Europe. Note that strain PG1, located by the legend, was not positioned on the map because its geographic origin is unknown. Strains of group A are found in sub-Saharan Africa and nowhere else. This could be an indication that CBPP was present in Africa prior to colonisation time.
On the other hand the genomic link between strains from European origin (group C) and those found in Southern Africa, Australia, India and some found in East Africa (group B) can be correlated with historical data describing CBPP expansion during colonisation in the 19th century. Note that strain PG1, located by the legend, was not positioned on the map because its geographic origin is unknown. Figure 5 . Tree obtained by eBURST for group A strains. Group A is subdivided into 13 allelic profiles and gathers strains found only in sub-Saharan Africa. The largest allelic profile (A12) comprises four strains. However, these strains were collected in neighbouring countries on well known cattle trade routes. This is a likely explanation for finding strains of similar allelic profiles at different locations. the exact origin and year of isolation (before 1931) of the strain are unknown. More likely, the divergence of PG1 may result from the many in vitro passages. A single housekeeping gene (ftsY) was validated for use in the new MLSA scheme. It was noteworthy that polymorphisms in this gene included the presence of duplicated nonanucleotides coding for a stretch of three amino acids (DQQ) present in three to five copies, as well as the deletion of a rather long DNA fragment (35 bp). Since this gene, coding for a bacterial signal-recognition particle receptor, plays a fundamental role in mediating membrane targeting and insertion of nascent proteins [2] , it is likely that the polymorphic sites are not positioned on the active sites of this molecule.
Epidemiological analysis
The presence of group A strains only in West and central Africa may indicate that these strains have evolved separately from those present in Europe. This may also indicate that CBPP existed in the continent prior to colonisation and presumed introduction of CBPP with live cattle. Such a hypothesis was already raised when a traditional "vaccination" procedure, consisting in inoculating pleural fluid subcutaneously at the bridge of the nose, was described in West Africa [4] . The local inflammation generally led to a reaction of the periosteum, with development of a pseudo-horn, which resulted in the erroneous description of a new cattle breed called Bos triceros [35] . These traditional procedures were unknown in Europe, where the inoculation point, as described by Willems, was the tip of the tail [49] . Furthermore, a possible ancestral allelic profile (A00) was identified in strains isolated in Chad and the Gemu-Gofa region in Western Ethiopia. In these regions the influx of exotic cattle was minimal in the 19th century. In contrast, the presence of group B strains in East Africa could reflect an influx of affected cattle from Europe. This may have taken place directly from European countries (i.e. from Italy to its Eritrean colony) or indirectly, as when the 1868 British expedition to Abyssinia used oxcarts from India to pull artillery in the mountainous regions [19] and might have thus introduced CBPP in East Africa.
The geographic location of strains sharing the same allelic profile agreed with known epidemiological data. Therefore, the presence of multiple strains with the same allelic profile certainly does not result from an MLSA lack of discriminatory power. For example, the presence of allelic profile A05 in many countries in Eastern Africa can be explained by a 'clonal expansion' of the initial strain of Kenyan origin that led to the re-contamination of countries such as Tanzania and Rwanda in the 1990s [25] . Similarly, the presence of the same allelic profile (A12) in Mali, Burkina Faso, and Ivory Coast is in agreement with the transhumance and trade routes followed by cattle herds that are raised in Sahelian countries and exported to meat markets near large cities in the South.
Although strain PO1967, of European origin, belongs to group C, its sequence in Loc-PG1-0233 showed that it is closely related to Group B strains. The localisation of Group B strains in this MLSA scheme corroborated what was known regarding the transmission of CBPP from Europe to overseas colonies during the 19th century. It is well known that CBPP was exported from Europe to Southern Africa [41] , Australia [15, 28] , and India [36] at that time. The European strain linked to this group, PO1967, is the oldest strain from our collection, which was isolated in 1967 on the French-Spanish border. This strain may represent the closest relative to the ancestral strains that circulated in Europe in the 19th century. More recent European strains differ from PO1967 notably by a deletion of 8.8 kbp, which includes genes encoding a glycerol transporter that may be associated with MmmSC virulence [30, 44] . Unfortunately MmmSC strains circulating prior to 1967 in Europe are not available. They could have been used to monitor the genetic drift and to check if they were genetically closer to MmmSC strains of Southern Africa.
Recent strains of European origin displayed peculiar alleles that were not observed in non-European strains, notably on Loc-PG1-0233 which was not retained in the MLSA scheme. This finding indicates further that recent CBPP outbreaks in Europe were not due to a reintroduction, but were more likely to be a resurgence of the disease. This conclusion should be of major concern to European countries, particularly with regards to the widening of EU borders. The unnoticed persistence of MmmSC in Europe may be explained either by the existence of another, yet unidentified, reservoir or by the circulation of strains of lowpathogenicity, which may sometimes regain virulence. The presence of MmmSC strains in hosts other than cattle and domestic buffaloes has already been described. This is notably the case of goats, from which MmmSC strains have been regularly isolated both in Africa and in Europe and in which lesions of CBPP can sometimes be reproduced [13] . In an attempt to examine whether goats may be used in place of cattle as models for CBPP, various inoculation routes were tested by Yaya et al. [51] . Some inoculated goats seroconverted and one animal, inoculated intra-peritoneally, developed lesions. However, the role of goats in the natural epidemiology of CBPP is certainly marginal, if not completely irrelevant. This was evidenced in Botswana in 1994, when this country decided to slaughter the entire cattle population from the infected zone [27] . Although the goat population was not targeted in the stamping-out campaign, the subsequent reintroduction of naive cattle in this country was not followed by CBPP outbreaks, hence showing that goats did not play a significant role in CBPP persistence and long term transmission, at least in this context.
On the contrary, the unnoticed circulation of low-pathogenic MmmSC strains in Europe remains a possible explanation for the resurgence of CBPP. It is well known that MmmSC strains show various degrees of virulence. However, strain virulence is difficult to measure since (i) there is no small animal model that can mimic the lesions observed in cattle, (ii) endobronchial inoculations in cattle are not always successful, even when using strains that have shown to be highly virulent in the field, and (iii) in-contact transmission trials are usually carried out with a reduced number of animals, which may not guarantee the evaluation of the strain virulence in a single experiment. This last point has been verified in silico with stochastic transmission models showing that successive trials performed with the same initial parameters may lead to very different outcomes [21] .
MLST is an unambiguous procedure for characterising isolates of bacterial species based on the sequences of the internal fragments of house-keeping genes [23, 37] . The sequences of approximately 500 bp are normally used, as these can be accurately sequenced on both strands using an automated DNA sequencer. For each house-keeping gene, the different sequences present within a bacterial species are assigned as distinct alleles and each isolate is characterised by an allelic profile, corresponding to the alleles defined in each of the loci. In MLST analyses the number of nucleotide differences found between alleles is disregarded and sequences are given different allele numbers whether they differ at a single or at many nucleotide positions. The rationale for this is that a single genetic event resulting in a new allele can occur by a point mutation, altering only a single nucleotide site, or by a recombinational replacement that will often result in the modification of multiple sites. This typing scheme has been applied successfully to a wide variety of bacterial pathogens such as Staphylococcus aureus [14] , Campylobacter jejuni [12] , and Haemophilus influenzae [26] , to cite only a few. This approach has multiple applications such as phylogeny [18] , molecular structure analysis [42] , and molecular epidemiology. In molecular epidemiology, MLST can be used to study the evolution of antibiotic resistant strains [17] , the temporal trends in strain expansion [29] , or the distribution of strains of various lineages within a population [20] .
In the case of MmmSC, this approach was not successful, since the variability within housekeeping genes was too limited, if present at all. This was the case of the genes fusA, lepA, and rpoB. In terms of an evolutionary perspective this may indicate that MmmSC genomes are extremely homogeneous, suggesting that this mycoplasma has adapted very recently to its bovine host. From a practical point of view, this means that genes of unknown function or non coding sequences had to be selected in this study to differentiate MmmSC strains. This is why the strategy has alternatively been named "multilocus sequence analysis". This typing scheme is less universal than MLST analyses, since the gene targets used were selected for typing strains within a biotype and would not be suitable for typing strains of higher taxonomic ranks. However, like MLST, MLSA has the advantage of being a portable and very robust approach.
This new MmmSC typing scheme proved more robust than the previous one developed in our laboratory [22] . No double bands were obtained after PCR amplification, which ensured that PCR products could be sent without any purification step. This was sometimes the case with the previous MLSA. On the contrary, the new scheme allowed the description of 31 profiles instead of only 15 out of a comparable number of strains (51 and 48 respectively).
MLSA analysis may open new perspectives for a better understanding of MmmSC genome plasticity. In this respect, it would be very interesting to obtain ancestral DNA from samples of CBPP-affected lungs preserved in formalin for histology. This should allow the characterisation of the ancestral allelic profiles circulating in Europe and Africa and may permit measuring evolution rates for the various loci.
This MLSA strategy may also be applied to better understand CBPP epidemiology, improving thus the surveillance and control of the disease. New loci may be added to increase the discriminating power of the MLSA tool on subsets of strains that are very closely related. Including a large number of strains isolated from goats in various regions of the world would be very interesting in order to examine whether the MLSA profiles of MmmSC strains from goat origin are similar or, on the contrary, more closely related to other MmmSC strains circulating in the same region. The fact that caprine species may serve as a reservoir should be an incentive to multiply mycoplasma isolation and identification from this host, which is known to harbour mycoplasmas in the ear canal in the absence of pathological signs. Such a procedure is already in place in France, conducted by an epidemiological network called VIGIMYC, managed by the Agence Française de Sécurité Sanitaire des Aliments in Lyon.
The results obtained in this study will be included in a web tool dedicated to molecular epidemiology within an EU-funded project called EPIZONE. This tool should facilitate the dissemination of typing methods for pathogens threatening Europe, allow any laboratory to compare in-house data with large databank sets and, in turn, generate phylogenetic trees and actualised maps, provided that the geographic coordinates of all isolates are known. Such a tool should naturally be linked to the websites of the OIE (http://www.oie.int/wahid-prod/) and FAO (http://www.fao.org/ag/againfo/programmes/ en/empres/disease_cbpp.asp), which provide updated information on new outbreaks for notifiable diseases.
Finally, this new MLSA tool will be particularly useful to all countries at risk of CBPP reintroduction or resurgence and to those engaged in eradication campaigns, allowing them to trace back the origin of any remaining CBPP focus.
